Skip to main content

Table 1 Patient characteristics and treatment details

From: Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography

Patient number

Other treatments to cure LL except for conservative therapy before TL

Diagnosis

Surgery

LL location

Daily chyle/lymph output (mL/day)

Time interval between surgery and TL (days)

Volume of iodinated oil injected in TL (mL)

Interval between TL and ALVS (days)

Volume of 95% ethanol injected in ALVS (mL)

Clinical outcomes of ALVS

Salvage treatment after clinically failed ALVS

Interval between ALVS and the cure of LL (days)

1

None

Esophagus carcinoma

Thoracic-abdominal esophagus resection + lymphadenectomy

Chylothorax

1,100

22

16.0

8

4.0

Clinical failure

Yes: surgical revision

13

2

None

Erosive esophagitis induced esophageal stenosis

Thoracic-abdominal esophagus resection + lymphadenectomy

Chylothorax

1,130

15

15.0

3

4.0

Clinical success

No

8

3

None

Thoracic aortic aneurysm (dislocation of the grafts)

Descending aorta replacement

Chylothorax

1,500

14

15.0

8

2.0

Clinical success

No

7

4

Surgical revision

Cutaneous Merkel cell carcinoma

Inguinal lymphadenectomy

Inguinal lymphatic fistula

200

28

9.0

5

5.0

Clinical success

No

8

5

Surgical revision

Penile carcinoma

Inguinal lymphadenectomy

Inguinal lymphatic fistula

340

24

20.0

13

2.0

Clinical success

No

7

6

Surgical revision

Malignant melanoma

Inguinal lymphadenectomy

Inguinal lymphatic fistula

100

70

5.0

10

1.0

Clinical success

No

1

7

None

Chondrosarcoma

Bone tumour resection

Lymphatic fistula at the thigh

300

13

6.0

11

2.0

Clinical success

No

20

8

Doxycycline instillation (100 mg/3 times)

Malignant melanoma

Inguinal lymphadenectomy

Lymphatic fistula at the thigh

100

18

10.0

18

2.0

Clinical success

No

3

9

None

Malignant melanoma

Inguinal lymphadenectomy

Lymphatic fistula at the thigh

100

36

10.0

28

2.0

Clinical success

No

1

  1. ALVS Afferent lymphatic vessel sclerotherapy, LL Lymphatic leakage, TL Transpedal lymphangiography